InvestorsHub Logo
Followers 6
Posts 1023
Boards Moderated 0
Alias Born 04/11/2011

Re: Backstabbed post# 25531

Tuesday, 03/20/2012 2:31:58 PM

Tuesday, March 20, 2012 2:31:58 PM

Post# of 95629
What BIG NEWS could come out in a PR that would be bigger than several that have come out with what should have had a positive impact for a positive market reaction.
ROLLBACK, UPGRADE, DISTRIBUTION,MARKETING, PRODUCT LINE and yet we dropped within % points of quad zeros.
So with all due respect BACKSTABBED things have done a complete 180.

PHAR does not have license to sell AQUAPRIN or any additional lines due to never being validated by a third party. Its not in compliance with FDA and will have to be validated by a totally unrelated 3rd party or it cannot be produced.
IMO that is a huge question mark as you would think after first try failed testing in early stages it would have been a tremendous asset to draw investors to have this done.
In 2009 ,with AQUAPRIN qouted by CEO/Howrd as to being fully ready, corrections made,in stability and dissolvement issue you have to be concerned as to why Howard also qouted this witH to me a very telling ONE word that gets overlooked INTENDS.
QUOTE from below link in 2009. "Pharmstar INTENDS to carry out some clinical trials on AQUAPRIN to satisfy the US FDA and FTC about its marketing claims of "fastest acting" , "safest" and " most potent analgesic on the market".
http://www.pharmaceutical-technology.com/projects/pharmastar/

Imo no testing was ever done since that intention which had to be completed even then to produce product as stated OR it failed then and or has failed recently when the same claim was made at the outset that 3rd party testing was UNDERWAY.

What possible explanation is there not to put this valuable and most important part "first" to make this more attractive to market and investor interest and raising capital.
GLTU